Your browser doesn't support javascript.
loading
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.
Nassiri, Farshad; Patil, Vikas; Yefet, Leeor S; Singh, Olivia; Liu, Jeff; Dang, Rachel M A; Yamaguchi, Takafumi N; Daras, Mariza; Cloughesy, Timothy F; Colman, Howard; Kumthekar, Priya U; Chen, Clark C; Aiken, Robert; Groves, Morris D; Ong, Shirley S; Ramakrishna, Rohan; Vogelbaum, Michael A; Khagi, Simon; Kaley, Thomas; Melear, Jason M; Peereboom, David M; Rodriguez, Analiz; Yankelevich, Maxim; Nair, Suresh G; Puduvalli, Vinay K; Aldape, Kenneth; Gao, Andrew; López-Janeiro, Álvaro; de Andrea, Carlos E; Alonso, Marta M; Boutros, Paul; Robbins, Joan; Mason, Warren P; Sonabend, Adam M; Stupp, Roger; Fueyo, Juan; Gomez-Manzano, Candelaria; Lang, Frederick F; Zadeh, Gelareh.
Afiliación
  • Nassiri F; Division of Neurosurgery, University of Toronto, Toronto, Ontario, Canada.
  • Patil V; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
  • Yefet LS; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
  • Singh O; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
  • Liu J; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
  • Dang RMA; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
  • Yamaguchi TN; Department of Human Genetics, University of California Los Angeles, Los Angeles, CA, USA.
  • Daras M; Department of Human Genetics, University of California Los Angeles, Los Angeles, CA, USA.
  • Cloughesy TF; Division of Neuro-oncology, University of California San Francisco, San Francisco, CA, USA.
  • Colman H; UCLA Neuro-Oncology Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Kumthekar PU; Huntsman Cancer Institute and Department of Neurosurgery, University of Utah, Salt Lake City, UT, USA.
  • Chen CC; Department of Neurology, Division of Neuro-Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Aiken R; Department of Neurosurgery, University of Minnesota, Minneapolis, MI, USA.
  • Groves MD; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.
  • Ong SS; Department of Neurology, Texas Oncology, Austin, TX, USA.
  • Ramakrishna R; Division of Neuro-Oncology, Department of Neurology, the Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Vogelbaum MA; Department of Neurological Surgery, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA.
  • Khagi S; Department of Neuro-Oncology, Neuro-Oncology Program, Moffitt Cancer Center, Tampa, FL, USA.
  • Kaley T; Division of Medical Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Melear JM; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Peereboom DM; Department of Internal Medicine, Baylor University Medical Center, Dallas, TX, USA.
  • Rodriguez A; The Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH, USA.
  • Yankelevich M; Department of Neurosurgery, University of Arkansas for Medical Sciences, Little Rock, AK, USA.
  • Nair SG; Department of Pediatrics, University of Michigan, Ann Arbor Beaumont Children's Hospital, Royal Oak, MI, USA.
  • Puduvalli VK; Lehigh Valley Topper Cancer Institute, Allentown, PA, USA.
  • Aldape K; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Gao A; Laboratory of Pathology, National Cancer Institute, Bethesda, MD, USA.
  • López-Janeiro Á; Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto, Ontario, Canada.
  • de Andrea CE; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain.
  • Alonso MM; Navarra Institute for Health Research (IdISNA), Pamplona, Spain.
  • Boutros P; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain.
  • Robbins J; Navarra Institute for Health Research (IdISNA), Pamplona, Spain.
  • Mason WP; Navarra Institute for Health Research (IdISNA), Pamplona, Spain.
  • Sonabend AM; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.
  • Stupp R; Program of Solid Tumors, Center for the Applied Medical Research (CIMA), Pamplona, Spain.
  • Fueyo J; Department of Human Genetics, University of California Los Angeles, Los Angeles, CA, USA.
  • Gomez-Manzano C; DNATrix Inc., Carlsbad, CA, USA.
  • Lang FF; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
  • Zadeh G; Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Nat Med ; 29(6): 1370-1378, 2023 Jun.
Article en En | MEDLINE | ID: mdl-37188783
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Glioblastoma / Virus Oncolíticos / Viroterapia Oncolítica Tipo de estudio: Clinical_trials Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Glioblastoma / Virus Oncolíticos / Viroterapia Oncolítica Tipo de estudio: Clinical_trials Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article